To investigate the impact of B-cell activation on the glycome, naïve CD21pos B cells from HD were cultured for 48 h in vitro with CpG, anti-IgM, anti-IgM/IFN-γ, or without stimulation. The gene discussed is CD40LG; the disease is Huntington disease.